- Home
- Publications
- Publication Search
- Publication Details
Title
NSAIDs and COVID-19: A Systematic Review and Meta-analysis
Authors
Keywords
-
Journal
DRUG SAFETY
Volume 44, Issue 9, Pages 929-938
Publisher
Springer Science and Business Media LLC
Online
2021-08-02
DOI
10.1007/s40264-021-01089-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts
- (2021) Angel YS Wong et al. ANNALS OF THE RHEUMATIC DISEASES
- Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection
- (2021) Jennifer S. Chen et al. JOURNAL OF VIROLOGY
- Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?
- (2021) Sergio Verd et al. Frontiers in Pharmacology
- Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Eugenia Abaleke et al. LANCET
- Non-steroidal anti-inflammatory agent use may not be associated with mortality of coronavirus disease 19
- (2021) Jungchan Park et al. Scientific Reports
- Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19
- (2021) Aditya Sahai et al. VASCULAR MEDICINE
- Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
- (2021) Thomas M Drake et al. Lancet Rheumatology
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
- (2020) Gianluca Trifirò et al. DRUG SAFETY
- SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
- (2020) Gabriela M Kuster et al. EUROPEAN HEART JOURNAL
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection
- (2020) Joëlle Micallef et al. THERAPIE
- Covid-19: ibuprofen can be used for symptoms, says UK agency, but reasons for change in advice are unclear
- (2020) Ingrid Torjesen BMJ-British Medical Journal
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Association between NSAIDs use and adverse clinical outcomes among adults hospitalized with COVID-19 in South Korea: A nationwide study
- (2020) Han Eol Jeong et al. CLINICAL INFECTIOUS DISEASES
- Ibuprofen use and clinical outcomes in COVID-19 patients
- (2020) E. Rinott et al. CLINICAL MICROBIOLOGY AND INFECTION
- Does Ibuprofen Worsen COVID-19?
- (2020) Nicholas Moore et al. DRUG SAFETY
- Rationale for the use of N -acetylcysteine in both prevention and adjuvant therapy of COVID-19
- (2020) Silvio De Flora et al. FASEB JOURNAL
- Independent Correlates of Hospitalization in 2040 Patients with COVID-19 at a Large Hospital System in Michigan, United States
- (2020) Zaid Imam et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID‐19 patients in Michigan, United States
- (2020) Z. Imam et al. JOURNAL OF INTERNAL MEDICINE
- Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study
- (2020) Jong-moon Hwang et al. NEUROLOGICAL SCIENCES
- COVID-19 and NSAIDs: Primum non nocere
- (2020) Joëlle Micallef et al. THERAPIE
- Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
- (2020) Shruti Gupta et al. JAMA Internal Medicine
- Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19
- (2020) Eilidh Bruce et al. Journal of Clinical Medicine
- The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19
- (2020) Francesca Silvagno et al. Antioxidants
- COVID-19 and NSAIDS: A Narrative Review of Knowns and Unknowns
- (2020) Joseph V. Pergolizzi et al. Pain and Therapy
- The COVID‐19 ibuprofen controversy: A systematic review of NSAIDs in adult acute lower respiratory tract infections
- (2020) Ricky Vaja et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Association Between Prescribed Ibuprofen and Severe COVID‐19 Infection: A Nationwide Register‐Based Cohort Study
- (2020) Kristian Kragholm et al. CTS-Clinical and Translational Science
- Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
- (2020) Remo H M Furtado et al. LANCET
- Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review
- (2020) Hajira Dambha-Miller et al. BMJ Open
- Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study
- (2020) Lars Christian Lund et al. PLOS MEDICINE
- Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
- (2020) Shruti Gupta et al. JAMA Internal Medicine
- Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?
- (2020) Piero Sestili et al. Frontiers in Pharmacology
- ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror
- (2020) Mina T. Kelleni INFLAMMOPHARMACOLOGY
- Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes
- (2020) Mina T. Kelleni BIOMEDICINE & PHARMACOTHERAPY
- COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence
- (2020) Félicie Costantino et al. JOINT BONE SPINE
- Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID‐19
- (2020) Joht Singh Chandan et al. Arthritis & Rheumatology
- Ibuprofen Attenuates Cardiac Fibrosis in Streptozotocin-Induced Diabetic Rats
- (2015) Weili Qiao et al. CARDIOLOGY
- Targeting the gastrointestinal tract to develop novel therapies for HIV
- (2015) RK Reeves et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Ibuprofen and/or paracetamol (acetaminophen) for pain relief after surgical removal of lower wisdom teeth, a Cochrane systematic review
- (2014) E. Bailey et al. BRITISH DENTAL JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started